Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 6
1994 2
1995 5
1996 3
1997 8
1998 10
1999 11
2000 13
2001 9
2002 14
2003 20
2004 9
2005 12
2006 23
2007 9
2008 11
2009 10
2010 14
2011 14
2012 22
2013 7
2014 14
2015 20
2016 14
2017 16
2018 14
2019 16
2020 14
2021 12
2022 9
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer.
Park DJ, Kwon TG, Park JY, Joung JY, Ha HK, Jeon SS, Hong SH, Park S, Lee SH, Cho JS, Park SW, Kwon SY, Jo JK, Park HS, Lee SC, Kwon DD, Kim SI, Park SH, Kim S, Jeong CW, Kwak C, Choi SH; Korean Urologic Oncology Society Prostate Cancer Group. Park DJ, et al. Among authors: ha hk. World J Mens Health. 2024 Jan 2. doi: 10.5534/wjmh.230104. Online ahead of print. World J Mens Health. 2024. PMID: 38164028 Free article.
Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.
Sayed S, Koka H, Abubakar M, Gardner K, Salgado R, Moloo Z, Caban-Ureña AB, Rosen D, Castro P, Saleh M, Shaikh AJ, Shah J, Figueroa J, Makokha F, Ha HK, Wang Z, Magangane P, Naidoo R, Ngundo V, Yang XR, Govender D. Sayed S, et al. Among authors: ha hk. Breast Cancer Res Treat. 2023 Jun;199(2):401-413. doi: 10.1007/s10549-023-06921-3. Epub 2023 Apr 3. Breast Cancer Res Treat. 2023. PMID: 37010652
Patients' self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational study.
Hong SH, Chung HS, Seo IY, Kwon TG, Jeong H, Chung JI, Jeon SH, Park JY, Ha HK, Chung BH, Song W, Kim YJ, Kim SH, Lee JS, Lee J, Chung J. Hong SH, et al. Among authors: ha hk. J Patient Rep Outcomes. 2022 Dec 16;6(1):125. doi: 10.1186/s41687-022-00532-0. J Patient Rep Outcomes. 2022. PMID: 36525150 Free PMC article.
340 results